Announcements Trials

Browse Landscape

Status

No longer available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Plasma cell 4 Lymphoid 3 Dermatologic 3 CNS 2 Thoracic 1 Sarcoma 1 Other solid neoplasm 1 Other hematologic neoplasm 1 Gastrointestinal 1

Conditions

Interventions

Injections 98 pembrolizumab 90 Carboplatin 57 Paclitaxel 54 Cisplatin 52 Nivolumab 44 Docetaxel 43 Pemetrexed 42 Gemcitabine 37 atezolizumab 32 tislelizumab 29 Bevacizumab 29 toripalimab 23 Fluorouracil 23 Capecitabine 23 Irinotecan 22 Oxaliplatin 20 durvalumab 19 Ipilimumab 18 Leucovorin 17 Cetuximab 17 Rifampin 14 Itraconazole 14 olaparib 13 spartalizumab 12 Midazolam 12 Cyclophosphamide 12 trifluridine tipiracil drug combination 11 sintilimab 11 Drug Therapy 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × marizomib × Other solid neoplasm × Clear all

NCT04644107 2020-11-25

Expanded Access for Marizomib

Celgene

No longer available

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡